Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Agreed that leronlimab is the clear common sense

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Venture_Cap Member Profile
 
Followed By 68
Posts 7,506
Boards Moderated 1
Alias Born 09/28/12
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/15/2020 5:06:59 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 9/14/2020 4:31:44 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/1/2020 5:34:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 2:57:56 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 9/1/2020 1:47:41 PM
MICROCAP DAILY - The Exciting Story of Puration Inc (OTCMKTS: PURA) InvestorsHub NewsWire - 8/26/2020 9:02:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:31:34 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/14/2020 5:19:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 5:21:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 4:34:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 5:07:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 4:31:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:19:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 7:24:49 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 6/8/2020 5:28:53 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/8/2020 6:02:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 5:01:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/2/2020 8:01:17 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 5/15/2020 8:47:08 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2020 6:00:59 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/30/2020 5:28:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 5:29:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2020 5:03:47 PM
Venture_Cap   Friday, 07/03/20 10:59:16 PM
Re: BioInvestor4 post# 90575
Post # of 119164 
Agreed that leronlimab is the clear common sense solution right now.

But the article stated “studies” on going and Ryoncil and Brilacidin are both successful candidates to also “fit the narrative”. Granted they can’t be distributed yet so it’s a tease.

My point is don’t be disappointed if Trump and Co tout yet another useless solution to calm the panic. A placebo announcement, lol. See remdesivir or HCQ.

I don’t think they have the data yet on Leron. They will soon though and when they do the market will be calmer and they’ll make yet another announcement but this time about leronlimab.

Let’s just hope the Feds don’t expedite manufacturing of Ryoncil.... by that I mean 6-9 months with an executive order.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences